age
float64 18
102
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
| event_times
int64 3
2.03k
| event_indicators
int64 0
1
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
65.16095
|
male
| 0
| 21
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 8
| null | 0
| 27,118.438
| 18,046.5625
| null | 20.333328
|
white
| 30.199219
| 44
| 0.710938
| 0.550903
| 1
| 1
| 0
|
no
| 0.8
| 0.7
|
dnr after sadm
| 4
| 63
| 7.299805
| 100
| 11
| 36.39844
| 300
| 3
| null | 2.799805
| 130
| 7.439453
| null | null | null | 4
| null | null | 3.183199
| 214
| 1
|
37.50598
|
male
| 1
| 9
|
Coma
|
Coma
| 1
| 12
|
$11-$25k
| 61
| 69,511.312
| 44,734.5625
| null | 29.5
|
white
| 20
| 17
| 0.653931
| 0.593994
| 23
| 0
| 0
|
no
| null | null |
dnr after sadm
| 2
| 113
| 4.5
| 44
| 6
| 36.89844
| 547.5
| null | null | 0.899902
| 154
| 7.429688
| null | null | null | null | null |
<2 mo. follow-up
| 2.008789
| 9
| 1
|
71.56195
|
female
| 1
| 43
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 11
|
under $11k
| 26
| 171,998.75
| 108,769.625
| null | 38.75
|
white
| 25.5
| 42
| 0.566895
| 0.455994
| 23
| 1
| 0
|
no
| 0.5
| 0.4
|
dnr after sadm
| 27
| 123
| 6.799805
| 120
| 7
| 38.69531
| 450
| 1.799805
| 6.199219
| 0.699951
| 150
| 7.5
| null | null | null | null | null |
<2 mo. follow-up
| 2.337891
| 43
| 1
|
71.95599
|
female
| 0
| 10
|
CHF
|
COPD/CHF/Cirrhosis
| 0
| null | null | 0
| 15,265.047
| 10,070.7109
| null | 20
|
black
| 26.898438
| 29
| 0.737915
| 0.587891
| 1
| 0
| 0
|
no
| 0.9
| 0.75
|
no dnr
| 10
| 75
| 10.398438
| 106
| 26
| 36.79688
| 234.78125
| 2.399902
| 0.799927
| 0.699951
| 141
| 7.389648
| null | null | null | null | null | null | 2.376953
| 1,348
| 0
|
63.52399
|
male
| 0
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 5
|
under $11k
| 0
| 8,887.242
| 6,031.0938
| null | 11.5
|
white
| 22.898438
| 23
| 0.826904
| 0.768921
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 7
| 67
| 17.597656
| 126
| 20
| 35.79688
| 312
| null | 0.699951
| 1
| 139
| 7.459961
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,348
| 0
|
45.24597
|
male
| 1
| 3
|
Coma
|
Coma
| 0
| 12
|
$11-$25k
| 89
| 29,102.234
| 18,106.1875
| null | 48
|
white
| 81.09375
| 80
| 0
| 0
| 3
| 0
| 0
|
no
| null | null |
dnr after sadm
| 2
| 0
| 15.099609
| 0
| 0
| 39.19531
| 195
| null | null | 2
| 181
| 7.40918
| null | null | null | null | null |
<2 mo. follow-up
| 1.310547
| 3
| 1
|
78.86896
|
male
| 1
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 26
| 60,337.531
| 35,466.3125
| null | 22
|
white
| 27.5
| 41
| 0.496948
| 0.379944
| 8
| 0
| 0
|
no
| null | null |
dnr after sadm
| 4
| 105
| 16
| 110
| 32
| 38.5
| 197.125
| null | null | 2.699707
| 136
| 7.429688
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 7
| 1
|
42.215
|
female
| 0
| 110
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
| null | 0
| 166,448.625
| 111,714.688
| null | 19.75
|
black
| 31.796875
| 49
| 0.717896
| 0.631958
| 7
| 0
| 0
|
no
| null | null |
no dnr
| 110
| 160
| 29.898438
| 130
| 42
| 38.29688
| 170
| 2.5
| 4.399414
| 0.699951
| 133
| 7.399414
| null | null | null | null | null |
adl>=4 (>=5 if sur)
| 2.564941
| 1,345
| 0
|
33.66699
|
male
| 0
| 11
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 9
|
under $11k
| 0
| 29,377.688
| 20,656.7031
| null | 25
|
white
| 20.597656
| 32
| 0.893921
| 0.822998
| 1
| 0
| 0
|
no
| 0.6
| 0.5
|
no dnr
| 11
| 108
| 5.299805
| 74
| 26
| 38.5
| 300
| 2.299805
| 7.399414
| 0.699951
| 136
| 7.419922
| null | null | null | 2
| null | null | 1.839
| 1,345
| 0
|
81.53296
|
female
| 0
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 14
|
$11-$25k
| 26
| 25,805.188
| 17,326.8438
| null | 24
|
white
| 20.5
| 33
| 0.724976
| 0.640991
| 1
| 0
| 1
|
no
| 0.5
| 0.3
|
dnr after sadm
| 3
| 107
| 10.298828
| 126
| 30
| 38.59375
| 240
| 2.799805
| 0.199982
| 0.799927
| 143
| 7.389648
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 26
| 1
|
43.88998
|
male
| 0
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 20
|
$11-$25k
| 0
| 48,116.688
| 31,653.0781
| null | 21.666656
|
white
| 30.597656
| 37
| 0.75
| 0.670898
| 4
| 0
| 0
|
no
| 1
| 1
|
no dnr
| 14
| 100
| 16.699219
| 114
| 25
| 36.59375
| 147.5
| 3
| 0.5
| 1.699951
| 153
| 7.509766
| null | null | null | null | 1
|
SIP>=30
| 1
| 1,345
| 0
|
69.07599
|
female
| 0
| 11
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 8
|
under $11k
| 0
| 12,173.898
| 8,183.8711
| null | 17.5
|
white
| 24.597656
| 25
| 0.78894
| 0.661987
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 11
| 49
| 8.898438
| 66
| 24
| 35.59375
| 385.6875
| null | 0.5
| 0.699951
| 138
| 7.40918
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 269
| 1
|
54.56799
|
male
| 1
| 18
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 0
| null | 0
| 89,779.188
| 57,363.9688
| null | 45.666657
|
black
| 40.296875
| 60
| 0.516968
| 0.40094
| 1
| 0
| 0
|
no
| 0.5
| 0.4
|
dnr after sadm
| 17
| 56
| 4.099609
| 136
| 14
| 38.09375
| 128
| 2.599609
| 4.299805
| 4.5
| 141
| 7.489258
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 18
| 1
|
31.034
|
female
| 0
| 14
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 8
|
$11-$25k
| 55
| 62,115.281
| 39,471.7188
| null | 29.666656
|
white
| 23.199219
| 44
| 0.424988
| 0.305969
| 17
| 0
| 0
|
yes
| 0.5
| 0.1
|
dnr after sadm
| 4
| 110
| 11.599609
| 124
| 32
| 39
| 300
| 1.899902
| 0.399963
| 1.5
| 146
| 7.399414
| null | null | null | null | 5
|
<2 mo. follow-up
| 5
| 47
| 1
|
78.78998
|
female
| 1
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 15
|
$25-$50k
| 9
| 53,350.75
| 35,540.5
| null | 31
|
white
| 39.695313
| 80
| 0.21698
| 0.119995
| 11
| 0
| 0
|
no
| 0.4
| 0.5
|
no dnr
| 10
| 115
| 0.799927
| 136
| 32
| 34.79688
| 480
| 2.099609
| 0.699951
| 3.599609
| 138
| 7.479492
| null | null | null | null | 5
|
<2 mo. follow-up
| 5
| 10
| 1
|
68.20294
|
male
| 0
| 35
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$25-$50k
| 0
| 141,644.125
| 89,196.3125
| null | 31
|
white
| 31.796875
| 53
| 0.565918
| 0.453979
| 10
| 0
| 0
|
no
| null | null |
no dnr
| 35
| 53
| 41.5
| 90
| 15
| 37.59375
| 260
| 2.799805
| 1.099854
| 3.299805
| 127
| 7.509766
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 37
| 1
|
21.506
|
female
| 0
| 25
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$11-$25k
| 0
| 78,420.438
| 50,620.8125
| null | 36.5
|
black
| 27
| 33
| 0.879883
| 0.837891
| 2
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 25
| 63
| 25.699219
| 120
| 28
| 38.59375
| 147.5
| 2.799805
| 0.799927
| 0.699951
| 137
| 7.419922
| null | null | null | null | 0
| null | 0
| 1,341
| 0
|
52.05197
|
male
| 0
| 26
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 15
|
$25-$50k
| 26
| null | null | null | 29.25
|
white
| 26.199219
| 36
| 0.799927
| 0.677979
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 26
| 150
| 9.298828
| 136
| 24
| 36.09375
| 188
| 3
| 0.199982
| 0.799927
| 143
| 7.389648
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,339
| 0
|
36.00497
|
female
| 0
| 15
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 17
| null | 0
| 34,299.781
| 22,116.7969
| null | 22
|
white
| 21.097656
| 34
| 0.882935
| 0.804932
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 15
| 63
| 9.398438
| 72
| 10
| 36.39844
| 213.3125
| 2.399902
| 5.099609
| 0.799927
| 133
| 7.439453
| null | null | null | null | 6
| null | 6
| 109
| 1
|
71.10199
|
male
| 0
| 12
|
Lung Cancer
|
Cancer
| 1
| 8
|
$25-$50k
| 0
| 16,560.844
| 10,550.1875
| null | 10
|
white
| 25.097656
| 15
| 0.493958
| 0.173981
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 12
| 78
| 9.5
| 98
| 20
| 36.89844
| 347.5625
| 2.799805
| 0.5
| 0.599976
| 141
| 7.439453
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 259
| 1
|
77.03198
|
female
| 1
| 4
|
Coma
|
Coma
| 0
| 11
|
under $11k
| 61
| 22,531.438
| 13,481.4766
| null | 33
|
white
| 22.199219
| 23
| 0.334961
| 0.261963
| 1
| 0
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 3
| 108
| 11.5
| 106
| 32
| 36.09375
| 414.25
| null | null | 0.899902
| 134
| 7.609375
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 4
| 1
|
55.42499
|
male
| 0
| 25
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| 19
| null | 26
| 74,816.188
| 47,502.25
| null | 24.75
|
white
| 27.199219
| 37
| 0.585938
| 0.393982
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 25
| 61
| 10.699219
| 120
| 8
| 35.69531
| 162.5
| 1.5
| 1.799805
| 1.299805
| 135
| 7.419922
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 39
| 1
|
53.84299
|
male
| 0
| 28
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 7
|
under $11k
| 0
| 68,604.688
| 43,377.3125
| null | 27.5
|
white
| 21.597656
| 22
| 0.875977
| 0.792969
| 1
| 1
| 0
|
no
| 0.5
| 0.45
|
no dnr
| 28
| 60
| 9.898438
| 126
| 24
| 38.5
| 273.3125
| 3.099609
| 0.399963
| 0.899902
| 133
| 7.389648
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 244
| 1
|
44.89499
|
male
| 0
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 11
| null | 0
| 35,564.938
| 22,103.875
| null | 24.5
|
black
| 30.699219
| 48
| 0.778931
| 0.707886
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 9
| 72
| 11.298828
| 58
| 28
| 38.69531
| 102.5
| 3
| 0.199982
| 3
| 141
| 7.399414
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,335
| 0
|
72.34198
|
male
| 0
| 4
|
Lung Cancer
|
Cancer
| 2
| 8
| null | 0
| 4,382.75
| 2,688.4356
| null | 9
|
white
| 18.796875
| 18
| 0.651978
| 0.345947
| 1
| 1
| 0
|
metastatic
| 0.9
| 0.7
|
no dnr
| 4
| 109
| 11.898438
| 76
| 16
| 36.79688
| null | 3.099609
| 0.299988
| 0.899902
| 140
| null | null | null | null | null | null |
no(M2 and SIP pres)
| 2.300781
| 125
| 1
|
58.491
|
male
| 1
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 9
| 19,705.547
| 12,076.5703
| null | 51
|
black
| 35.296875
| 63
| 0.584961
| 0.475952
| 1
| 1
| 0
|
no
| null | null |
dnr after sadm
| 5
| 61
| 14.199219
| 134
| 44
| 37.69531
| 122
| 3
| 0.899902
| 2.699707
| 135
| 7.279297
| null | null | null | null | null |
<2 mo. follow-up
| 2.405762
| 6
| 1
|
61.91898
|
male
| 1
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 5
|
under $11k
| 37
| 53,453.531
| 32,532.9219
| null | 42.5
|
white
| 32.59375
| 48
| 0.440979
| 0.32196
| 4
| 0
| 0
|
no
| 0.5
| 0.4
|
dnr after sadm
| 6
| 59
| 3.5
| 106
| 10
| 36.29688
| 197.5
| 3.399902
| 1.899902
| 7
| 133
| 7.25
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 7
| 1
|
91.20898
|
male
| 0
| 28
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null |
$25-$50k
| 37
| 175,216.125
| 115,518
| null | 24.75
|
white
| 26.898438
| 49
| 0.335999
| 0.219971
| 24
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 28
| 74
| 11.898438
| 70
| 32
| 37.69531
| 222.84375
| 3.299805
| 11
| 1.5
| 154
| 7.429688
| null | null | null | null | null | null | 3.289063
| 63
| 1
|
64.97998
|
female
| 1
| 24
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 16
|
under $11k
| 37
| 80,000.812
| 53,980
| null | 38.666657
|
white
| 38.09375
| 60
| 0.31897
| 0.204987
| 1
| 1
| 0
|
no
| 0.3
| 0.2
|
dnr after sadm
| 23
| 115
| 19.699219
| 134
| 26
| 37.89844
| 115.54688
| 1.399902
| 1.699951
| 2.899902
| 129
| 7.399414
| null | null | null | null | null |
<2 mo. follow-up
| 2.566406
| 24
| 1
|
72.24097
|
male
| 0
| 24
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 0
| null | 0
| 143,222.5
| 87,619.625
| null | 46.333313
|
white
| 32.5
| 46
| 0.495972
| 0.377991
| 26
| 0
| 0
|
no
| 0.6
| 0.5
|
no dnr
| 24
| 121
| 4.399414
| 134
| 29
| 36.5
| 193.3125
| null | null | 2.699707
| 137
| 7.399414
| null | null | null | null | null | null | 2.198731
| 60
| 1
|
75.67395
|
female
| 1
| 23
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 14
|
$11-$25k
| 9
| 171,279.125
| 106,489.75
| null | 49
|
white
| 33.898438
| 61
| 0.40094
| 0.281982
| 14
| 1
| 0
|
no
| null | null |
dnr after sadm
| 23
| 60
| 22.5
| 136
| 9
| 35.89844
| 202.5
| 2.399902
| 3.099609
| 2
| 152
| 7.40918
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 23
| 1
|
25.56899
|
female
| 0
| 38
|
Coma
|
Coma
| 0
| 17
|
$11-$25k
| 44
| 85,945.312
| 57,810.7188
| null | 22.25
|
white
| 24.796875
| 19
| 0.781982
| 0.73999
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 38
| 73
| 6.899414
| 40
| 8
| 35
| 519
| 3.799805
| 1.5
| 0.599976
| 142
| 7.519531
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 1,331
| 0
|
58.81198
|
male
| 1
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 9
| 54,651.594
| 33,309.8125
| null | 42.5
|
black
| 33.09375
| 53
| 0.54895
| 0.434998
| 10
| 1
| 0
|
no
| 0.4
| 0.1
|
dnr after sadm
| 11
| 76
| 12.599609
| 130
| 30
| 36.19531
| 187.5
| 2.299805
| null | 3.199707
| 134
| 7.449219
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 11
| 1
|
66.92395
|
male
| 0
| 7
|
Colon Cancer
|
Cancer
| 1
| 15
|
$11-$25k
| 0
| 7,351.648
| 4,601.1953
| null | 10.5
|
white
| 14
| 15
| 0.850952
| 0.670898
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.5
|
no dnr
| 7
| 107
| 5.399414
| 64
| 20
| 37.09375
| null | null | 0.799927
| 1
| 141
| null | null | null | null | null | 0
| null | 0
| 183
| 1
|
78.78699
|
male
| 1
| 74
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
| null | 41
| null | null | null | 37.5
|
white
| 30.199219
| 59
| 0.323975
| 0.209991
| 12
| 0
| 0
|
no
| 0.5
| 0.4
|
no dnr
| 74
| 83
| 25.097656
| 120
| 4
| 38.39844
| 157.5
| 2.399902
| 1.199951
| 1.699951
| 137
| 7.30957
| null | null | null | null | 0
| null | 0
| 74
| 1
|
27.661
|
male
| 0
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 0
| 22,497.688
| 14,607.8906
| null | 12
|
black
| 19
| 14
| 0.92395
| 0.896973
| 3
| 0
| 0
|
no
| 1
| 1
|
no dnr
| 7
| 110
| 14.398438
| 100
| 22
| 36.29688
| 260
| 2.5
| null | 0.899902
| 138
| 7.449219
| null | null | null | null | null | null | 2.190918
| 1,327
| 0
|
58.823
|
male
| 1
| 23
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
| null | 0
| 109,539.875
| 70,529.375
| null | 44
|
white
| 25.5
| 40
| 0.746948
| 0.666992
| 13
| 1
| 0
|
no
| 0.6
| 0.5
|
dnr after sadm
| 16
| 117
| 12.798828
| 110
| 13
| 36.39844
| 180
| 1.199951
| 0.799927
| 0.899902
| 133
| 7.419922
| null | null | null | null | 4
|
<2 mo. follow-up
| 4
| 23
| 1
|
73.37994
|
female
| 0
| 45
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 41
| null | null | null | 16.5
|
black
| 21.699219
| 33
| 0.592896
| 0.484985
| 17
| 0
| 0
|
no
| 0.8
| 0.85
|
no dnr
| 45
| 124
| 6.299805
| 116
| 28
| 37.79688
| 204
| null | null | 0.899902
| 144
| 7.439453
| null | null | null | null | 0
| null | 0
| 676
| 1
|
54.431
|
female
| 0
| 4
|
Colon Cancer
|
Cancer
| 1
| null | null | 0
| 2,386.049
| 1,735.0772
| null | 13
|
white
| 24.199219
| 12
| 0.723999
| 0.448975
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 4
| 76
| 5
| 104
| 20
| 39
| null | 2.799805
| null | 0.899902
| 137
| null | null | null | null | null | null | null | 1.887451
| 261
| 1
|
70.12195
|
female
| 1
| 24
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 37
| 92,355.25
| 54,605
| null | 53
|
black
| 27.5
| 32
| 0.543945
| 0.429993
| 3
| 0
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 22
| 56
| 14.199219
| 124
| 10
| 35.69531
| 237.125
| null | 0.099991
| 1.199951
| 154
| 7.529297
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 24
| 1
|
76.20496
|
male
| 1
| 11
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 12
|
$11-$25k
| 41
| 38,628.625
| 24,617.3281
| null | 40.5
|
white
| 36.296875
| 90
| 0.075989
| 0.028
| 2
| 0
| 0
|
metastatic
| 0.1
| 0.001
|
dnr before sadm
| 0
| 59
| 0.099991
| 136
| 28
| 36.39844
| 250
| 1.899902
| 2.199707
| 2.099609
| 143
| 7.429688
| null | null | null | null | 3
|
<2 mo. follow-up
| 3
| 11
| 1
|
80.71198
|
female
| 0
| 34
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 61
| 61,520.188
| 41,577.7188
| null | 24.25
|
white
| 15.199219
| 13
| 0.666992
| 0.570923
| 4
| 0
| 0
|
no
| 0.25
| 0.1
|
no dnr
| 34
| 75
| 9.599609
| 66
| 9
| 37.5
| 225.6875
| 2.599609
| null | 0.699951
| 141
| 7.479492
| null | null | null | null | 3
|
adl>=4 (>=5 if sur)
| 3
| 1,324
| 0
|
47.918
|
male
| 0
| 5
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 10
|
under $11k
| 0
| 3,757
| 2,664.832
| null | 4
|
black
| 26.796875
| 48
| 0.75293
| 0.609985
| 1
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 5
| 118
| 15.599609
| 91
| 44
| 37.89844
| null | 2.399902
| 22
| 1.099854
| 136
| null | null | null | null | 0
| 0
|
<2 mo. follow-up
| 0
| 37
| 1
|
68.32599
|
male
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
|
$11-$25k
| 0
| 20,914.094
| 14,036.7734
| null | 17.5
|
white
| 31.5
| 41
| 0.598999
| 0.409973
| 6
| 1
| 0
|
no
| 0.7
| 0.3
|
no dnr
| 7
| 46
| 12.199219
| 60
| 32
| 36.39844
| 338.0625
| null | null | 1
| 128
| 7.519531
| null | null | null | 1
| 0
|
<2 mo. follow-up
| 0
| 57
| 1
|
58.03699
|
male
| 1
| 16
|
Coma
|
Coma
| 1
| null | null | 100
| null | null | null | 24
|
white
| 23.296875
| 43
| 0.294983
| 0.223999
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 4
| 109
| 14.298828
| 130
| 28
| 39
| 270
| 1.799805
| 0.799927
| 1.699951
| 141
| 7.349609
| null | null | null | null | null |
<2 mo. follow-up
| 2.536133
| 16
| 1
|
54.63098
|
female
| 0
| 113
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 7
|
under $11k
| 0
| null | null | null | 38.75
|
white
| 24
| 27
| 0.784912
| 0.713989
| 16
| 0
| 0
|
no
| 0.4
| 0.4
|
no dnr
| 113
| 99
| 23.5
| 184
| 14
| 38.5
| 236.65625
| null | 0.799927
| 0.399963
| 135
| 7.449219
| null | null | null | null | 7
| null | 7
| 1,321
| 0
|
54.40399
|
female
| 0
| 31
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| null | null | 41
| 77,659.062
| 52,406.4375
| null | 29.5
|
white
| 26.898438
| 50
| 0.672974
| 0.576904
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 31
| 69
| 5.799805
| 106
| 23
| 38.59375
| 113.84375
| 1.599854
| 0.899902
| 1.699951
| 142
| 7.55957
| null | null | null | null | null | null | 2.958008
| 1,320
| 0
|
70.43695
|
female
| 1
| 21
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 196,870.625
| 117,628.062
| null | 52
|
white
| 41.5
| 71
| 0.265991
| 0.159973
| 11
| 0
| 0
|
no
| null | null |
dnr after sadm
| 19
| 59
| 46.5
| 138
| 30
| 35.89844
| 272.5
| null | 5.199219
| 4.399414
| 127
| 7.359375
| null | null | null | null | null |
<2 mo. follow-up
| 2.1875
| 21
| 1
|
68.85095
|
male
| 0
| 16
|
Colon Cancer
|
Cancer
| 1
| null | null | 0
| 18,922.438
| 12,394.3828
| null | 16.666656
|
white
| 28.597656
| 50
| 0.580933
| 0.260986
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 16
| 133
| 13.699219
| 128
| 36
| 39.29688
| 276
| null | 6.099609
| 0.899902
| 134
| 7.489258
| null | null | null | null | null | null | 2.616211
| 220
| 1
|
54.08899
|
female
| 0
| 57
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 6
| null | 37
| 121,103.375
| 80,398.8125
| null | 25.5
|
black
| 21.398438
| 41
| 0.787964
| 0.718994
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 57
| 113
| 7.5
| 110
| 30
| 38.19531
| 368
| 2.799805
| 0.5
| 2.299805
| 144
| 7.469727
| null | null | null | null | 6
| null | 6
| 1,319
| 0
|
66.349
|
male
| 0
| 9
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 14
|
under $11k
| 0
| 13,372.742
| 9,138.5938
| null | 21.5
|
black
| 31.199219
| 36
| 0.684937
| 0.517944
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 9
| 127
| 14.699219
| 126
| 6
| 36.29688
| 182.84375
| 2.399902
| 0.5
| 1.399902
| 139
| 7.379883
| null | null | null | 1
| null |
SIP>=30
| 1.1669
| 1,320
| 0
|
60.89297
|
female
| 0
| 9
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
| null | 0
| 15,443.594
| 11,158.2109
| null | 14
|
white
| 19
| 16
| 0.882935
| 0.803955
| 1
| 0
| 0
|
no
| 0.8
| 0.6
|
no dnr
| 9
| 103
| 13.898438
| 64
| 24
| 35.59375
| 252
| null | null | 1.199951
| 137
| 7.449219
| null | null | null | 2
| null |
<2 mo. follow-up
| 1.839
| 11
| 1
|
44.89798
|
male
| 1
| 5
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 12
|
under $11k
| 26
| 26,682.391
| 18,153.2812
| null | 42
|
white
| 39.09375
| 85
| 0.360962
| 0.168976
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 5
| 45
| 5.599609
| 174
| 36
| 38.19531
| 206
| 2.199707
| 11.699219
| 1.199951
| 132
| 7.55957
| null | null | null | null | 3
|
<2 mo. follow-up
| 3
| 5
| 1
|
69.20197
|
female
| 0
| 10
|
Lung Cancer
|
Cancer
| 1
| null | null | 0
| 6,285.047
| 4,821.9883
| null | 7
|
white
| 18.898438
| 9
| 0.657959
| 0.35498
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 10
| 93
| 9.298828
| 100
| 16
| 35.39844
| null | null | 0.5
| 0.899902
| 138
| null | null | null | null | null | null |
<2 mo. follow-up
| 2.80957
| 41
| 1
|
56.06299
|
female
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 5
| 12
| null | 0
| 8,491.492
| 5,716.0938
| null | 9
|
black
| 19.5
| 25
| 0.888916
| 0.813965
| 1
| 1
| 0
|
no
| 0.7
| 0.5
|
no dnr
| 5
| 73
| 9.699219
| 52
| 24
| 36.79688
| 376.1875
| null | null | 1.699951
| 136
| 7.419922
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,317
| 0
|
75.14294
|
male
| 0
| 54
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 8
| null | 0
| 218,304.75
| 141,797.875
| null | 37.25
|
white
| 32.796875
| 57
| 0.339966
| 0.223999
| 17
| 0
| 0
|
yes
| null | null |
no dnr
| 54
| 133
| 0.299988
| 134
| 24
| 39
| 231.40625
| 2.399902
| 4.399414
| 1
| 152
| 7.429688
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 595
| 1
|
77.42596
|
male
| 0
| 21
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 12
|
$11-$25k
| 0
| 42,596.344
| 28,186.9375
| null | 26.333328
|
white
| 33.796875
| 66
| 0.545898
| 0.432983
| 1
| 1
| 0
|
no
| 0.75
| 0.6
|
no dnr
| 21
| 63
| 15.798828
| 60
| 0
| 34.89844
| 343.3125
| 2.5
| null | 5.5
| 131
| 7.5
| null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 697
| 1
|
64.51196
|
female
| 0
| 6
|
Colon Cancer
|
Cancer
| 1
| 15
|
$11-$25k
| 0
| 8,172.75
| 4,955.9102
| null | 16
|
white
| 15.898438
| 13
| 0.831909
| 0.633911
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 6
| 104
| 4.5
| 76
| 20
| 36.19531
| null | 3.399902
| 0.399963
| 0.799927
| 142
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,292
| 1
|
57.57199
|
male
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 16
| null | 0
| 3,218.248
| 2,497.7969
| null | 12
|
hispanic
| 21.699219
| 28
| 0.86499
| 0.776978
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 6
| 110
| 8.099609
| 96
| 24
| 36.79688
| null | null | null | 3
| 144
| null | null | null | null | 1
| null | null | 1.1669
| 284
| 1
|
82.52698
|
male
| 1
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 5
|
under $11k
| 26
| 27,246.438
| 16,079.7734
| null | 37.5
|
black
| 53.796875
| 68
| 0.007
| 0
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 7
| 39
| 15.898438
| 134
| 20
| 36.69531
| 108.75
| 2.799805
| 0.399963
| 3.799805
| 132
| 7.319336
| null | null | null | null | 6
|
<2 mo. follow-up
| 6
| 7
| 1
|
64.961
|
female
| 0
| 42
|
MOSF w/Malig
|
ARF/MOSF
| 0
| 11
|
under $11k
| 37
| null | null | null | 14.5
|
black
| 22
| 43
| 0.55188
| 0.438965
| 3
| 0
| 0
|
yes
| 0.75
| 0.5
|
no dnr
| 42
| 137
| null | 106
| 30
| 38.5
| 350
| 2
| null | 2
| 132
| 7.469727
| null | null | null | null | 1
|
adl>=4 (>=5 if sur)
| 1
| 564
| 1
|
90.71594
|
female
| 1
| 5
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 18
| null | 9
| 21,404.297
| 13,206.875
| null | 26
|
black
| 35.695313
| 54
| 0.306946
| 0.19397
| 3
| 0
| 0
|
no
| 0.25
| 0.2
|
dnr after sadm
| 5
| 108
| 12
| 100
| 36
| 35.19531
| 91.82812
| null | null | 1.899902
| 135
| 7.439453
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 5
| 1
|
69.21594
|
female
| 0
| 34
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 9
|
under $11k
| 0
| 86,351.562
| 55,435.9688
| null | 40
|
white
| 31.5
| 70
| 0.481995
| 0.363953
| 2
| 1
| 0
|
yes
| null | null |
no dnr
| 34
| 67
| 1.099854
| 170
| 32
| 35.79688
| 336.625
| 1.799805
| 0.599976
| 1.299805
| 147
| 7.299805
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 55
| 1
|
56.37198
|
male
| 1
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 17
| null | 0
| 42,452.438
| 27,247.7812
| null | 41.5
|
white
| 29.898438
| 59
| 0.668945
| 0.572998
| 2
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 6
| 56
| 16.699219
| 140
| 12
| 39.89844
| 240
| 1.799805
| 3.199707
| 1.899902
| 143
| 7.359375
| null | null | null | null | null |
<2 mo. follow-up
| 2.12207
| 13
| 1
|
44.67398
|
female
| 0
| 5
|
Colon Cancer
|
Cancer
| 3
| 12
|
$11-$25k
| 0
| 2,538.799
| 1,843.1514
| null | 9
|
white
| 15.398438
| 14
| 0.86792
| 0.702881
| 1
| 1
| 0
|
metastatic
| null | null |
no dnr
| 5
| 73
| 4.799805
| 80
| 20
| 36.59375
| null | null | 0.5
| 0.599976
| 136
| null | null | null | null | null | null |
no(M2 and SIP pres)
| 1.945557
| 134
| 1
|
26.752
|
male
| 0
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 10
| null | 0
| 35,316.125
| 23,421.3906
| null | 23
|
black
| 36.398438
| 46
| 0.756958
| 0.679932
| 1
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 14
| 51
| 21.699219
| 130
| 12
| 39.39844
| 108
| 2.199707
| 1.699951
| 1
| 137
| 7.349609
| null | null | null | null | 0
| null | 0
| 1,310
| 0
|
23.26399
|
male
| 0
| 22
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 11
| null | 9
| 93,008.875
| 58,490.0625
| null | 36.666657
|
black
| 25.5
| 34
| 0.86499
| 0.817993
| 4
| 0
| 0
|
no
| null | null |
no dnr
| 22
| 110
| 20.199219
| 110
| 38
| 38.69531
| 150
| 2.099609
| 0.899902
| 0.899902
| 143
| 7.449219
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,309
| 0
|
88.172
|
male
| 1
| 7
|
Coma
|
Coma
| 1
| null | null | 55
| 17,919.734
| 12,661.3359
| null | 15
|
white
| 17.898438
| 17
| 0.378967
| 0.304993
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 3
| 89
| 14.699219
| 54
| 14
| 37.09375
| 433.3125
| null | null | 1.099854
| 135
| 7.55957
| null | null | null | null | 4
|
<2 mo. follow-up
| 4
| 7
| 1
|
49.711
|
female
| 0
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 8
| null | 0
| 49,613.438
| 31,112.6875
| null | 23
|
white
| 27.199219
| 29
| 0.751953
| 0.67395
| 15
| 0
| 0
|
no
| 0.9
| 0.88
|
no dnr
| 14
| 82
| 8.898438
| 112
| 42
| 37.59375
| 180
| null | null | 0.5
| 131
| 7.5
| null | null | null | null | 2
|
no(M2 and SIP pres)
| 2
| 1,309
| 0
|
66.02295
|
female
| 1
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 10
|
under $11k
| 0
| 68,266.188
| 41,666.3125
| null | 50
|
white
| 25.898438
| 39
| 0.747925
| 0.668945
| 3
| 0
| 0
|
no
| 0.4
| 0.35
|
dnr after sadm
| 10
| 61
| 8
| 120
| 40
| 39.19531
| 147.25
| null | null | 0.799927
| 135
| 7.449219
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 11
| 1
|
73.86694
|
female
| 0
| 38
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 11
|
under $11k
| 44
| 139,384.25
| 91,699.9375
| null | 24.5
|
white
| 17.898438
| 16
| 0.672974
| 0.577881
| 13
| 0
| 0
|
no
| null | null |
dnr after sadm
| 21
| 63
| 9.099609
| 100
| 11
| 37.39844
| 336
| 3
| null | 0.5
| 140
| 7.479492
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 145
| 1
|
76.97998
|
male
| 1
| 16
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| null | null | 0
| 58,267.438
| 38,300.0938
| null | 36.333313
|
white
| 39.296875
| 69
| 0.302979
| 0.190979
| 1
| 0
| 0
|
yes
| 0.6
| 0.55
|
dnr after sadm
| 11
| 45
| 4.299805
| 74
| 14
| 37.89844
| 92
| 1.5
| 0.399963
| 2.599609
| 148
| 7.199219
| null | null | null | null | null |
<2 mo. follow-up
| 3.002441
| 16
| 1
|
58.92999
|
female
| 0
| 79
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
under $11k
| 37
| 128,515.375
| 85,647.1875
| null | 16.5
|
white
| 25.398438
| 51
| 0.642944
| 0.541992
| 5
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 79
| 137
| 16.898438
| 160
| 29
| 39
| 360
| 1.599854
| 0.699951
| 0.399963
| 136
| 7.459961
| null | null | null | null | 1
|
adl>=4 (>=5 if sur)
| 1
| 1,307
| 0
|
38.74597
|
female
| 0
| 20
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
$11-$25k
| 0
| 132,709.625
| 93,150.0625
| null | 15
|
white
| 25.5
| 37
| 0.807983
| 0.743896
| 39
| 1
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 20
| 109
| 1.699951
| 66
| 22
| 36.29688
| 290
| 1.599854
| 0.699951
| 1.899902
| 136
| 7.419922
| null | null | null | 0
| 0
| null | 0
| 1,307
| 0
|
29.62099
|
female
| 0
| 15
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
>$50k
| 89
| 53,349.375
| 34,999
| null | 34.666657
|
white
| 39.695313
| 35
| 0.17099
| 0.08699
| 1
| 0
| 0
|
yes
| 0.5
| 0.4
|
no dnr
| 15
| 75
| 2.699707
| 50
| 29
| 35.29688
| 256
| 2.699707
| 0.599976
| 0.5
| 118
| 7.449219
| null | null | null | null | 7
|
<2 mo. follow-up
| 7
| 19
| 1
|
64.54199
|
female
| 0
| 31
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| null | null | 0
| 213,444.5
| 144,919
| null | 17.5
|
white
| 22.699219
| 28
| 0.766968
| 0.629883
| 59
| 0
| 0
|
no
| null | null |
no dnr
| 31
| 112
| 7.599609
| 124
| 40
| 38
| 233.3125
| null | null | 0.5
| 139
| 7.40918
| null | null | null | null | null | null | 2.526367
| 100
| 1
|
77.40698
|
male
| 1
| 7
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 12
| null | 37
| 37,871.438
| 24,670.9062
| null | 23
|
white
| 43.398438
| 102
| 0
| 0
| 14
| 1
| 0
|
metastatic
| null | null |
dnr after sadm
| 6
| 51
| 4.599609
| 104
| 26
| 34.29688
| 176
| 1.399902
| 5.799805
| 4.5
| 137
| 7.329102
| null | null | null | null | 6
|
<2 mo. follow-up
| 6
| 7
| 1
|
55.491
|
female
| 0
| 33
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 15
|
$25-$50k
| 0
| 98,300.812
| 64,919.1562
| null | 26
|
white
| 21.199219
| 30
| 0.849976
| 0.797974
| 3
| 0
| 0
|
no
| null | null |
no dnr
| 33
| 111
| 6.899414
| 110
| 40
| 38.29688
| 373.3125
| 2.399902
| null | 0.5
| 141
| 7.349609
| null | null | null | null | 0
|
SIP>=30
| 0
| 1,301
| 0
|
74.96497
|
female
| 1
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 35,012.969
| 22,773.625
| null | 38.5
|
white
| 27.398438
| 56
| 0.651978
| 0.552979
| 6
| 0
| 0
|
no
| 0.3
| 0.3
|
no dnr
| 12
| 67
| 16.398438
| 150
| 48
| 36.29688
| 223.3125
| 2.299805
| 1.099854
| 1.599854
| 135
| 7.40918
| null | null | null | null | 5
|
<2 mo. follow-up
| 5
| 12
| 1
|
65.41498
|
female
| 0
| 14
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 14
|
under $11k
| 0
| 14,174
| null | null | 9.333328
|
white
| 20.199219
| 29
| 0.825928
| 0.716919
| 1
| 0
| 0
|
yes
| 0.8
| 0.8
|
dnr before sadm
| 0
| 80
| 8.699219
| 80
| 25
| 37.79688
| 201.65625
| 3.899902
| 0.799927
| 2.299805
| 139
| 7.319336
| 337
| 41
| 3,800
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 803
| 1
|
44.909
|
male
| 1
| 24
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
| null | 26
| 55,018
| null | null | 17.333328
|
white
| 43.398438
| 59
| 0.311951
| 0.198975
| 3
| 0
| 0
|
no
| 0.75
| 0.7
|
dnr after sadm
| 24
| 46
| 10.898438
| 122
| 33
| 36.09375
| null | 2.599609
| 1
| 1.299805
| 144
| null | 94
| 20
| 4,950
| null | 0
|
<2 mo. follow-up
| 0
| 24
| 1
|
65.31396
|
female
| 0
| 40
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
under $11k
| 0
| 57,653
| null | null | 23.25
|
white
| 26.398438
| 46
| 0.768921
| 0.694946
| 1
| 0
| 0
|
no
| 0.75
| 0.6
|
no dnr
| 40
| 73
| 7.399414
| 138
| 32
| 38.89844
| 400
| null | 0.699951
| 0.699951
| 138
| 7.419922
| 88
| 4
| 1,600
| null | 1
| null | 1
| 129
| 1
|
50.396
|
female
| 0
| 35
|
Coma
|
Coma
| 1
| 12
|
$25-$50k
| 44
| 90,395
| null | null | 24.75
|
white
| 26.296875
| 38
| 0.544922
| 0.475952
| 2
| 1
| 0
|
no
| 0.05
| 0.05
|
dnr after sadm
| 3
| 73
| 6.799805
| 54
| 22
| 36.69531
| null | 2.5
| 2.399902
| 0.599976
| 137
| null | 66
| 9
| 1,100
| null | 0
|
no(M2 and SIP pres)
| 0
| 1,086
| 0
|
39.26898
|
female
| 1
| 7
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 13
|
$25-$50k
| 9
| 75,303
| 47,321.2812
| 45,979
| 29
|
white
| 36.59375
| 83
| 0.169983
| 0.085999
| 20
| 0
| 0
|
metastatic
| 0.5
| 0
|
dnr after sadm
| 2
| 73
| 5.599609
| 80
| 25
| 37.79688
| 247.59375
| 3.599609
| 0.699951
| 2.5
| 138
| 7.489258
| 104
| 53
| null | null | 1
|
<2 mo. follow-up
| 1
| 7
| 1
|
69.13599
|
female
| 1
| 3
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 14
|
$25-$50k
| 0
| 18,689
| null | null | 46
|
white
| 75.296875
| 87
| 0
| 0
| 1
| 1
| 0
|
no
| 0.1
| 0.5
|
no dnr
| 3
| 73
| 23.597656
| 108
| 26
| 36.19531
| 410.6875
| 3.099609
| null | 1.199951
| 141
| 7.359375
| 291
| 38
| 1,605
| null | 2
|
<2 mo. follow-up
| 2
| 3
| 1
|
40.34998
|
female
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 13
| null | 0
| 2,466
| null | null | 8
|
black
| 22.699219
| 36
| 0.897949
| 0.828979
| 1
| 0
| 0
|
no
| 0.4
| 0.05
|
dnr after sadm
| 1
| 110
| 5.5
| 60
| 20
| 36.09375
| 276.1875
| null | null | 1.099854
| 137
| 7.349609
| 152
| 23
| 550
| 6
| null |
adl>=4 (>=5 if sur)
| 4.527344
| 70
| 1
|
67.87695
|
male
| 0
| 17
|
Colon Cancer
|
Cancer
| 1
| 12
| null | 0
| 32,329
| null | null | 19.333328
|
white
| 41.398438
| 33
| 0.218994
| 0.022999
| 1
| 0
| 0
|
metastatic
| 0.93
| 0.8
|
no dnr
| 17
| 67
| null | 60
| 25
| 38.29688
| 370.3125
| 2.599609
| null | 1.599854
| 142
| 7.419922
| 278
| 24
| 1,300
| null | 1
| null | 1
| 767
| 1
|
76.71997
|
female
| 0
| 8
|
Lung Cancer
|
Cancer
| 2
| 18
|
$11-$25k
| 0
| 11,391
| null | null | 15.5
|
white
| 22.796875
| 14
| 0.537964
| 0.214996
| 1
| 1
| 0
|
metastatic
| 0.8
| 0.6
|
no dnr
| 8
| 77
| 21.296875
| 80
| 20
| 36.09375
| 300
| null | 1.299805
| 0.899902
| 140
| 7.429688
| 136
| 11
| null | 3
| 1
| null | 1
| 736
| 1
|
47.52399
|
male
| 0
| 93
|
Coma
|
Coma
| 0
| 14
| null | 89
| 154,483
| 100,133.438
| 94,355
| 26.75
|
white
| 18.796875
| 16
| 0.541992
| 0.472961
| 3
| 0
| 0
|
no
| 0.8
| 0.75
|
dnr after sadm
| 42
| 56
| 5.099609
| 102
| 40
| 38.29688
| 330
| 2.899902
| null | 1.099854
| 136
| 7.479492
| 108
| 16
| 5,380
| null | 0
|
adl>=4 (>=5 if sur)
| 0
| 1,082
| 0
|
80.68994
|
female
| 1
| 4
|
Coma
|
Coma
| 2
| 6
|
$11-$25k
| 100
| 67,555
| null | null | 40
|
white
| 21.296875
| 37
| 0.064987
| 0.035995
| 15
| 1
| 0
|
no
| 0.05
| 0.05
|
dnr after sadm
| 3
| 107
| 7.399414
| 68
| 20
| 36.39844
| null | null | null | 0.799927
| 135
| null | 93
| 12
| null | null | null |
<2 mo. follow-up
| 3.039551
| 4
| 1
|
46.39297
|
male
| 0
| 29
|
MOSF w/Malig
|
ARF/MOSF
| 0
| null | null | 0
| 46,628
| null | null | 20.75
|
white
| 16.699219
| 17
| 0.835938
| 0.779907
| 1
| 0
| 0
|
yes
| 0.8
| 0.5
|
no dnr
| 29
| 52
| 12.298828
| 107
| 8
| 35.59375
| 135
| null | 0.5
| 2.899902
| 142
| 7.319336
| 99
| 65
| 2,095
| null | null | null | 1.986816
| 60
| 1
|
68.96899
|
male
| 1
| 4
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 13
| null | 0
| 46,514
| null | null | 50
|
white
| 53.898438
| 98
| 0.022999
| 0.004999
| 31
| 0
| 0
|
no
| 0.1
| 0.1
|
no dnr
| 4
| 107
| 9.599609
| 76
| 16
| 37.09375
| null | null | 0.5
| 1.099854
| 144
| null | 63
| 17
| null | null | 2
|
<2 mo. follow-up
| 2
| 4
| 1
|
67.67395
|
male
| 1
| 35
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
>$50k
| 37
| 162,435
| null | null | 37.75
|
hispanic
| 30.296875
| 72
| 0.41394
| 0.293945
| 15
| 0
| 0
|
no
| 0.2
| 0.2
|
dnr after sadm
| 35
| 70
| 5.899414
| 80
| 20
| 35.59375
| 400
| null | null | 2.099609
| 143
| 7.5
| 139
| 24
| null | null | 0
|
<2 mo. follow-up
| 0
| 35
| 1
|
58.22897
|
male
| 0
| 6
|
Colon Cancer
|
Cancer
| 1
| 16
|
>$50k
| 0
| 10,123
| null | null | 9
|
white
| 13.699219
| 6
| 0.866943
| 0.701904
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.6
|
no dnr
| 6
| 119
| 16.398438
| 102
| 28
| 35.59375
| 113.32812
| 2.5
| 0.299988
| 0.699951
| 137
| 7.509766
| 72
| 13
| 3,265
| 1
| 1
|
no(M2 and SIP pres)
| 1
| 195
| 1
|
55.99698
|
male
| 0
| 78
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 325,893
| null | null | 39
|
white
| 38.695313
| 54
| 0.441956
| 0.322998
| 15
| 0
| 0
|
no
| 0.95
| 0.95
|
no dnr
| 78
| 77
| 6.799805
| 70
| 20
| 36.09375
| null | 3.699707
| 2.099609
| 2.299805
| 138
| null | 120
| 35
| null | null | null |
Coma or Intub
| 2.189453
| 183
| 1
|
59.38397
|
male
| 0
| 41
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 8
|
under $11k
| 0
| 92,841
| 64,880.2812
| 57,448
| 22.75
|
white
| 28.898438
| 47
| 0.704956
| 0.615967
| 5
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 41
| 37
| 0.399963
| 188
| 10
| 36.09375
| 140
| 2.299805
| 1.299805
| 1
| 143
| 7.459961
| 150
| 31
| 2,235
| null | 1
|
adl>=4 (>=5 if sur)
| 1
| 1,078
| 0
|
34.853
|
female
| 0
| 29
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 16
|
$25-$50k
| 0
| 67,010
| null | null | 21
|
white
| 26.699219
| 24
| 0.850952
| 0.799927
| 2
| 0
| 0
|
no
| 0.7
| 0.7
|
no dnr
| 29
| 69
| 0.699951
| 77
| 32
| 39.39844
| 170
| 2.799805
| 2.099609
| 2.799805
| 134
| 7.469727
| 118
| 46
| 3,410
| null | 7
|
no(M2 and SIP pres)
| 7
| 1,077
| 0
|
68.39996
|
male
| 0
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 0
| 45,859
| null | null | 13.666664
|
white
| 16.597656
| 7
| 0.851929
| 0.800903
| 7
| 0
| 0
|
no
| 0.75
| 0.5
|
dnr after sadm
| 2
| 63
| 6.299805
| 110
| 6
| 39.89844
| 312.5
| null | null | 1.399902
| 132
| 7.329102
| 165
| 10
| 6,990
| null | 0
|
adl>=4 (>=5 if sur)
| 0
| 1,076
| 0
|
54.84198
|
male
| 0
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 15
|
$11-$25k
| 0
| 30,104
| 19,874.3594
| 17,731
| 15.5
|
black
| 24.796875
| 38
| 0.800903
| 0.734985
| 4
| 1
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 10
| 110
| 6.399414
| 116
| 46
| 39.19531
| 130
| null | 8.798828
| 1
| 129
| 7.439453
| 124
| 18
| 1,515
| 1
| 0
|
no(M2 and SIP pres)
| 0
| 1,076
| 0
|
51.19498
|
male
| 1
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 17
|
under $11k
| 0
| 110,430
| null | null | 36
|
white
| 33.59375
| 63
| 0.634888
| 0.532959
| 7
| 0
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 17
| 41
| 17.5
| 44
| 12
| 39
| 130
| 2.099609
| 2.599609
| 1.599854
| 145
| 7.429688
| 184
| 15
| 2,240
| null | null |
<2 mo. follow-up
| 2.17334
| 17
| 1
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.